Search research articles
Contact Us
Filters
Showing results (241-250 of 268) with videos related to
Page
of 27
Sort By:
European Journal of Endocrinology
|
August 18, 2022
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension
Maria Fleseriu, John Newell-Price, Rosario Pivonello, et al.
Reviews in Endocrine & Metabolic Disorders
|
June 11, 2025
Lights or shadows, a promising future for positron emission tomography in pituitary tumors: a systematic review
Sabrina Chiloiro, Carmelo Caldarella, Alessandra Vicari, et al.
European Journal of Endocrinology
|
September 29, 2022
Durable biochemical response and safety with oral octreotide capsules in acromegaly
Susan L Samson, Lisa B Nachtigall, Maria Fleseriu, et al.
European Journal of Endocrinology
|
August 3, 2021
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY
Maria Fleseriu, Dagmar Führer-Sakel, Aart J van der Lely, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 4, 2020
Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide
Susan L Samson, Lisa B Nachtigall, Maria Fleseriu, et al.
The Lancet. Diabetes & Endocrinology
|
July 31, 2020
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
Rosario Pivonello, Maria Fleseriu, John Newell-Price, et al.
Neurosurgery
|
September 17, 2016
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Posttreatment Follow-up Evaluation of Patients With Nonfunctioning Pituitary Adenomas
Mateo Ziu, Ian F Dunn, Christopher Hess, et al.
European Journal of Endocrinology
|
February 20, 2025
Delphi panel consensus on recommendations for thromboprophylaxis of venous thromboembolism in endogenous Cushing's syndrome: a position statement
Kristina Isand, Hiroshi Arima, Jerome Bertherat, et al.
The Lancet. Diabetes & Endocrinology
|
December 26, 2021
Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial
Maria Fleseriu, Alexander Dreval, Irina Bondar, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 23, 2025
Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-Daily Oral Paltusotine Treatment
Beverly M K Biller, Alessandra Casagrande, Atanaska Elenkova, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 268) with videos related to
Sort By:
Page
of 27
European Journal of Endocrinology
|
August 18, 2022
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension
Maria Fleseriu, John Newell-Price, Rosario Pivonello, et al.
Reviews in Endocrine & Metabolic Disorders
|
June 11, 2025
Lights or shadows, a promising future for positron emission tomography in pituitary tumors: a systematic review
Sabrina Chiloiro, Carmelo Caldarella, Alessandra Vicari, et al.
European Journal of Endocrinology
|
September 29, 2022
Durable biochemical response and safety with oral octreotide capsules in acromegaly
Susan L Samson, Lisa B Nachtigall, Maria Fleseriu, et al.
European Journal of Endocrinology
|
August 3, 2021
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY
Maria Fleseriu, Dagmar Führer-Sakel, Aart J van der Lely, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 4, 2020
Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide
Susan L Samson, Lisa B Nachtigall, Maria Fleseriu, et al.
The Lancet. Diabetes & Endocrinology
|
July 31, 2020
Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
Rosario Pivonello, Maria Fleseriu, John Newell-Price, et al.
Neurosurgery
|
September 17, 2016
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Posttreatment Follow-up Evaluation of Patients With Nonfunctioning Pituitary Adenomas
Mateo Ziu, Ian F Dunn, Christopher Hess, et al.
European Journal of Endocrinology
|
February 20, 2025
Delphi panel consensus on recommendations for thromboprophylaxis of venous thromboembolism in endogenous Cushing's syndrome: a position statement
Kristina Isand, Hiroshi Arima, Jerome Bertherat, et al.
The Lancet. Diabetes & Endocrinology
|
December 26, 2021
Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial
Maria Fleseriu, Alexander Dreval, Irina Bondar, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 23, 2025
Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-Daily Oral Paltusotine Treatment
Beverly M K Biller, Alessandra Casagrande, Atanaska Elenkova, et al.
Page
of 27